US SB2886 | 2023-2024 | 118th Congress
Status
Spectrum: Partisan Bill (Democrat 4-0)
Status: Introduced on September 21 2023 - 25% progression, died in committee
Action: 2023-09-21 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on September 21 2023 - 25% progression, died in committee
Action: 2023-09-21 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand names to do so.
Title
Updated Drug Labeling for Patient Safety Act
Sponsors
| Sen. Chris Van Hollen [D-MD] | Sen. Sherrod Brown [D-OH] | Sen. Richard Blumenthal [D-CT] | Sen. Christopher Coons [D-DE] |
History
| Date | Chamber | Action |
|---|---|---|
| 2023-09-21 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/senate-bill/2886/all-info |
| Text | https://www.congress.gov/118/bills/s2886/BILLS-118s2886is.pdf |
